top of page

Certification of medical device COLLAGENASE MB

Identification code: CZ.01.2.06/0.0/0.0/20_344/0026416

Expected finish of the project: 2023


COLLAGENASE MB is an innovative product that enables gentle separation of Lagerhans bodies from the donor pancreas. This ensures their better viability and function after transplantation. As part of the project, MB PHARMA will be provided with consulting services that will lead to the correct preparation of technical and administrative documents and to the successful notification of the COLLAGENASE MB product as a medical device.


This project is implemented with financial

support from the state budget

through the Ministry of Industry and Trade

bottom of page